Stocktoria
BioRestorative Therapies, Inc. BRTX
BioRestorative Therapies, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 93.4% | 93.0% | 100.0% | — | — | — | — | — | 100.0% | 99.7% |
| Operating margin | -4350.1% | -2881.6% | -10439.5% | -15838.1% | -57191.0% | -3574.1% | -6486.2% | -6889.8% | -10338.6% | -21414.0% |
| Net margin | -3959.4% | -2239.2% | -7145.2% | -15438.0% | -96311.5% | -14639.9% | -11267.6% | -11277.3% | -11660.1% | -23755.4% |
| FCF margin | -3031.7% | -2078.9% | -4527.6% | -5157.2% | -7305.6% | — | -5349.5% | -4610.4% | -4762.3% | -14279.8% |
| Return on assets | -349.1% | -73.1% | -82.6% | -112.5% | -197.3% | -259.3% | -999.0% | -1049.8% | -537.1% | -546.6% |
| Return on equity | -3992.2% | -105.3% | -104.1% | -179.7% | -205.1% | 846.6% | 114.7% | 144.9% | 138.1% | 172.7% |
| Debt / equity | — | — | — | — | 0.01× | — | — | — | — | — |
| Current ratio | 0.84 | 2.97 | 4.37 | 34.36 | 59.01 | 3.05 | 0.01 | 0.02 | 0.06 | 0.01 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.